Abstract | BACKGROUND: METHODS: We assessed fasting plasma homocysteine (Hcy) levels and main Hcy determinants, FVL and PTHRA(20210) in 30 patients with documented iCVT and 40 age- and sex-matched healthy subjects. RESULTS: A strong and significant association of PTHRA(20210) [30% (9/30) vs. 2.5% (1/40) iCVT vs. controls, respectively, p = 0.001; OR = 16.174, p = 0.002] and HHcy [13/30 (43.3%) vs. 4/40 (10%) iCVT vs. controls, respectively; p = 0.002, OR = 6.88, p = 0.002] with iCVT was found. CONCLUSIONS: PTHRA(20210) and HHcy should be considered when screening for thrombophilia and should be assessed in patients with a family or personal history of CVT.
|
Authors | Paolo Ventura, Milena Cobelli, Marco Marietta, Rossana Panini, Maria Cristina Rosa, Gianfranco Salvioli |
Journal | Cerebrovascular diseases (Basel, Switzerland)
(Cerebrovasc Dis)
Vol. 17
Issue 2-3
Pg. 153-9
( 2004)
ISSN: 1015-9770 [Print] Switzerland |
PMID | 14707415
(Publication Type: Journal Article)
|
Copyright | Copyright 2004 S. Karger AG, Basel |
Chemical References |
- Protein C
- Protein S
- factor V Leiden
- Homocysteine
- Antithrombin III
- Factor V
- Prothrombin
|
Topics |
- Adult
- Antithrombin III
(metabolism)
- Cerebral Veins
- Factor V
(genetics)
- Female
- Homocysteine
(blood)
- Humans
- Hyperhomocysteinemia
(epidemiology, genetics)
- Intracranial Thrombosis
(epidemiology, genetics)
- Male
- Point Mutation
- Prevalence
- Protein C
(metabolism)
- Protein S
(metabolism)
- Prothrombin
(genetics)
- Risk Factors
- Thrombophilia
(epidemiology, genetics)
- Venous Thrombosis
(epidemiology, genetics)
|